'''Thymopentin''' is an [[immunostimulant]]. As such, it has been used in several clinical studies in the early years of the [[AIDS]] pandemic (from 1983 to 1985). Thymopentin helped to improve immunological condition in several patients for a brief time under specific treatments.<ref name="pmid6193382">{{cite journal |vauthors=Mascart-Lemone F, Huygen K, Clumeck N,  Brenez D, Bolla K, Duchateau J |title=Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients |journal=Lancet |volume=322 |issue=8352 |pages=735–736 |year=1983 |pmid=6193382 |doi=10.1016/S0140-6736(83)92271-7 |url=http://www.lancet.com/journals/lancet/article/PIIS0140-6736(83)92271-7/fulltext}}</ref><ref name="pmid6398315">{{cite journal |vauthors=Clumeck N, Van de Perre P, Mascart-Lemone F,  Cran S, Bolla K, Duchateau J |title=Preliminary results on clinical and immunological effects of thymopentin in AIDS |journal=Int J Clin Pharmacol Res |volume=4 |issue= |pages=459–463 |year=1984 |pmid=6398315 |url=http://europepmc.org/abstract/MED/6398315}}</ref><ref name="pmid3898293">{{cite journal |vauthors=Clumeck N, Cran S, Van de Perre P, Mascart-Lemone F, Duchateau J, Bolla K |title=Thymopentin treatment in AIDS and pre-AIDS patients |journal=Surv Immunol Res |volume=4 |issue=1 |pages=supp1 58–62 |year=1985 |pmid=3898293  |url=https://link.springer.com/article/10.1007%2FBF02919057 |doi=10.1007/BF02919057}}</ref>

 
It is a [[thymic]] [[polypeptide]].<ref name="pmid18692582">{{cite journal  |vauthors=Peng Y, Chen Z, Yu W, etal |title=Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells |journal=Cell Biology International |volume= 32|issue= 10|pages= 1265–71|date=July 2008 |pmid=18692582 |doi=10.1016/j.cellbi.2008.07.011 |url=http://linkinghub.elsevier.com/retrieve/pii/S1065-6995(08)00501-5}}</ref>
